These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22173972)

  • 21. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
    Wang L; Sato H; Zhao S; Tooyama I
    Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.
    Saito T; Matsuba Y; Yamazaki N; Hashimoto S; Saido TC
    J Neurosci; 2016 Sep; 36(38):9933-6. PubMed ID: 27656030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice.
    Morales-Corraliza J; Berger JD; Mazzella MJ; Veeranna ; Neubert TA; Ghiso J; Rao MV; Staufenbiel M; Nixon RA; Mathews PM
    Neurobiol Aging; 2012 Jun; 33(6):1125.e9-18. PubMed ID: 22206846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
    López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
    Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
    Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
    Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β protein precursor regulates phosphorylation and cellular compartmentalization of microtubule associated protein tau.
    Nizzari M; Barbieri F; Gentile MT; Passarella D; Caorsi C; Diaspro A; Taglialatela M; Pagano A; Colucci-D'Amato L; Florio T; Russo C
    J Alzheimers Dis; 2012; 29(1):211-27. PubMed ID: 22232001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein.
    Kuwako K; Nishimura I; Uetsuki T; Saido TC; Yoshikawa K
    Brain Res Mol Brain Res; 2002 Nov; 107(2):166-75. PubMed ID: 12425945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of Aβ seeds in APP null mouse brain.
    Ye L; Fritschi SK; Schelle J; Obermüller U; Degenhardt K; Kaeser SA; Eisele YS; Walker LC; Baumann F; Staufenbiel M; Jucker M
    Nat Neurosci; 2015 Nov; 18(11):1559-61. PubMed ID: 26352792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence supporting the role of calpain in the α-processing of amyloid-β precursor protein.
    Nguyen HT; Sawmiller DR; Wu Q; Maleski JJ; Chen M
    Biochem Biophys Res Commun; 2012 Apr; 420(3):530-5. PubMed ID: 22480599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice.
    Medeiros R; Kitazawa M; Chabrier MA; Cheng D; Baglietto-Vargas D; Kling A; Moeller A; Green KN; LaFerla FM
    Am J Pathol; 2012 Aug; 181(2):616-25. PubMed ID: 22688056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
    Rao MV; Mohan PS; Peterhoff CM; Yang DS; Schmidt SD; Stavrides PH; Campbell J; Chen Y; Jiang Y; Paskevich PA; Cataldo AM; Haroutunian V; Nixon RA
    J Neurosci; 2008 Nov; 28(47):12241-54. PubMed ID: 19020018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
    Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
    Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease.
    Yang Y; Tapias V; Acosta D; Xu H; Chen H; Bhawal R; Anderson ET; Ivanova E; Lin H; Sagdullaev BT; Chen J; Klein WL; Viola KL; Gandy S; Haroutunian V; Beal MF; Eliezer D; Zhang S; Gibson GE
    Nat Commun; 2022 Jan; 13(1):159. PubMed ID: 35013160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer's disease models.
    Boländer A; Kieser D; Voss C; Bauer S; Schön C; Burgold S; Bittner T; Hölzer J; Heyny-von Haußen R; Mall G; Goetschy V; Czech C; Knust H; Berger R; Herms J; Hilger I; Schmidt B
    J Med Chem; 2012 Nov; 55(21):9170-80. PubMed ID: 22913544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pericyte loss influences Alzheimer-like neurodegeneration in mice.
    Sagare AP; Bell RD; Zhao Z; Ma Q; Winkler EA; Ramanathan A; Zlokovic BV
    Nat Commun; 2013; 4():2932. PubMed ID: 24336108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.